Skip to content

Author

Yu Kakimoto

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Efficacy of fenfluramine in a pediatric epilepsy patient with a pathogenic SV2A variant: A case report.

It is proposed that FFA's effectiveness stems from its ability to address two core pathologies of SV2A deficiency: correction of the excitatory/inhibitory imbalance by restoring inhibitory tone through its serotonergic mechanism, and mitigation of neuroinflammation, thereby stabilizing the neuronal network.

Takayuki Mori, Hiroshi Terashima, Yu Kakimoto et al. · 0 citations